Explore the key impact of generic drugs and biosimilars on reducing prescription costs in the U.S. healthcare system, including legislative efforts and market dynamics.

Explore how BCBS Michigan saved $147 million by transitioning to biosimilars, enhancing patient access while reducing healthcare costs. Learn more!